摘要
脂肪内分泌因子在维持全身能量平衡和糖脂代谢方面具有重要作用。越来越多的证据表明神经调节蛋白4(NRG4)与肥胖及代谢性疾病的发生发展有密切关系,未来通过深入的研究,NRG4有望成为具有治疗肥胖相关多种疾病生物制剂的潜力。
Adipoendocrine factor plays an important role in maintaining systemic energy balance and glycolipid metabolism. Increasing evidence has shown that neuregulin 4(NRG4) plays an important role in the development of obesity and metabolic disease. Future studies may result in the development of NRG4 as an effective therapeutic biologic for the treatment of obesity-associated disorders.
作者
程贤鹦
何银辉
Cheng Xianying;He Yinhui(Department of Gynecology and Obstetrics,Zhejiang Hospital,Hangzhou 310033,China;Department of Endocrinology,Lishui Central Hospital,the Fifth Affiliated Hospital of Wenzhou Medical University,Lishui Hospital of Zhejiang University,Lishui 323000,China)
出处
《中华临床医师杂志（电子版）》
CAS
2019年第9期684-688,共5页
Chinese Journal of Clinicians(Electronic Edition)
基金
浙江省中医药科技计划项目(2018ZB008)
